Home Tags Therapeutics

Tag: Therapeutics

Comparing of Unity Biotechnology Inc. (UBX) and Acorda Therapeutics Inc. (NASDAQ:ACOR)...

Unity Biotechnology Inc. (NASDAQ:UBX) and Acorda Therapeutics Inc. (NASDAQ:ACOR) compete with each other in the Biotechnology sector....

Arvelle Therapeutics raises $180m in Series A financing

Swiss newco Arvelle Therapeutics has baged a $180m (€159.1m) series A financing led by LSP. The company licenced the anti-epileptic candidate cenobamate (YKP3089) for $100m...

Xact Kapitalforvaltning AB Buys 3,100 Shares of Heron Therapeutics Inc (HRTX)

Xact Kapitalforvaltning AB boosted its stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 31.3% during the...

Aptevo Therapeutics Inc (APVO) Expected to Post Earnings of -$0.57 Per...

Equities analysts predict that Aptevo Therapeutics Inc (NASDAQ:APVO) will post earnings of ($0.57) per share for the current...

Brokerages Set Heron Therapeutics Inc (HRTX) Price Target at $53.70

Shares of Heron Therapeutics Inc (NASDAQ:HRTX) have been assigned an average rating of “Buy” from the fourteen ratings...

Prana Biotechnology Limited (PRAN)’s Financial Results Comparing With Revance Therapeutics Inc....

Both Prana Biotechnology Limited (NASDAQ:PRAN) and Revance Therapeutics Inc. (NASDAQ:RVNC) compete on a level playing field in...

Unity Biotechnology Inc. (UBX) and Magenta Therapeutics Inc. (NASDAQ:MGTA) Contrasting side...

Unity Biotechnology Inc. (NASDAQ:UBX) and Magenta Therapeutics Inc. (NASDAQ:MGTA) compete against each other in the Biotechnology sector. We will contrast them and...

Decibel Therapeutics taps 4G Clinical for RTSM support

Decibel Therapeutics, which focuses on therapies for hearing and balance disorders, has tapped 4G Clinical to provide randomization and trial supply management. 4G will, specifically,...

Cidara Therapeutics Inc (CDTX) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Cidara Therapeutics Inc (NASDAQ:CDTX) have earned an average recommendation of “Buy” from the six research firms...

IFM Therapeutics launches cGAS/STING-focused subsidiary for inflammatory and autoimmune disease

IFM Therapeutics is unveiling its second subsidiary, IFM Due, which will target the cyclic GMP-AMP Synthase, Stimulator of Interferon Genes (cGAS/STING) pathway to...

MOST POPULAR

HOT NEWS